Safety of Bioelectric Impedance Analysis Testing in Pediatric Patients With Cardiac Implantable Electronic Devices
Pacing and Clinical Electrophysiology · 03.11.2026
DOI: 10.1111/pace.70486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 03.11.2026. Verfasst von Allegra J VanderWilde und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Bioelectric impedance analysis (BIA) is a useful clinical tool in pediatric heart disease, but concerns regarding cardiac implanted electronic devices (CIEDs) limit its use. This study's goal was to assess the impact of BIA on CIED settings in pediatric patients.
Methods
This single‐center cohort study included two groups: a retrospective cohort of patients under 21 years old who had CIED interrogation within 12 months before and after BIA use, and a smaller prospective cohort who had CIED interrogation immediately before and after BIA use. The prospective group also underwent real‐time monitoring for electrical interference during BIA. Exclusion criteria included age, implanted loop recorders, and incomplete data. Analysis used either a paired t ‐test or a Wilcoxon signed‐rank test as appropriate, with p ‐value < 0.05 considered statistically significant.
Results
The retrospective cohort included 55 patients with 80 total tests. A statistically but not clinically significant difference in lead impedance was observed (513 [456, 627] v 513 [399, 593] ohms, p < 0.0001), though no differences were found in electrogram amplitudes, thresholds, or programmed output. When patients with multiple tests were analyzed, there remained a statistically significant difference in lead impedance (513 [399, 614] v 513 [375, 592] ohms, p = 0.0002) but not in other CIED parameters. In the prospective cohort ( n = 10), no electrical interference was appreciated during BIA, and there were no before‐and‐after differences in CIED sensing amplitudes. No inappropriate shocks or premature device failures occurred.
Conclusions
BIA was not associated with adverse events or meaningful changes in CIED function in this pediatric cohort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio, USA.
- The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Allegra J VanderWilde, Wayne A Mays, Adam W Powell
Zitieren
APA
VanderWilde, A. J., Knilans, T. K., Mays, W. A., Knecht, S. K., & Powell, A. W. (2026). Safety of Bioelectric Impedance Analysis Testing in Pediatric Patients With Cardiac Implantable Electronic Devices. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70486
Vancouver
VanderWilde AJ, Knilans TK, Mays WA, Knecht SK, Powell AW. Safety of Bioelectric Impedance Analysis Testing in Pediatric Patients With Cardiac Implantable Electronic Devices. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70486
BibTeX
@article{VanderWilde2026,
author = {VanderWilde, Allegra J and Knilans, Timothy K and Mays, Wayne A and Knecht, Sandra K and Powell, Adam W},
title = {Safety of Bioelectric Impedance Analysis Testing in Pediatric Patients With Cardiac Implantable Electronic Devices},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70486}
}
EUVIMED